RecruitingNot ApplicableNCT03989167

Clinical Decision Support for Familial Hypercholesterolemia

Clinical Decision Support for Familial Hypercholesterolemia: a Cluster Randomized Trial in the Primary Care Setting


Sponsor

University Hospital, Linkoeping

Enrollment

460,000 participants

Start Date

Dec 6, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

A cluster randomized study in the primary care setting to evaluate a computer-based clinical decision support system to aid in the identification and management of patients with FH. The primary outcome of the study is the number of patients diagnosed with FH thirty-six months after study initiation.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria1

  • Primary care centers in the county of Östergötland.

Exclusion Criteria1

  • Primary care centers not using the Cambio Cosmic Electronic Health Record System.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERClinical decision support

Computer-based support tool for identification of patients with high levels of total cholesterol or LDL-C, at high risk of being affected by FH.


Locations(1)

Universitetssjukhuset i Linköping

Linköping, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03989167


Related Trials